Souhaitez-vous accéder aux communiqués récents ?

IO Biotech Announces Publication of Five-year Clinical Outcomes of Phase 1/2 Trial in Nature Communications

Hays, Kansas, Dec. 15, 2025 (GLOBE NEWSWIRE) -- FHSU’s new hybrid pre-licensure Bachelor of Science in Nursing (BSN) program opened its inaugural semester with its first cohort of 10 students...

Salt Lake City, Utah, Dec. 15, 2025 (GLOBE NEWSWIRE) -- Novarad Corporation, a global leader in medical imaging and immersive augmented reality surgical navigation, today announced that the United...

Indianapolis, Indiana, Dec. 15, 2025 (GLOBE NEWSWIRE) -- TRIMEDX today announced the launch of TRIMEDX-AIQ™ , a breakthrough AI intelligence offering that sets a new standard for clinical asset...

New research in ONCOLOGY finds major gaps between cancer incidence and clinical trial enrollment, highlighting urgent needs for equity and better access.

Delray Beach, FL, Dec. 15, 2025 (GLOBE NEWSWIRE) -- Rapid innovation, expanding clinical pipelines, and rising demand for curative treatments position gene therapy as a transformative growth engine...

Company advances its mission to deliver next-generation diabetes management solutions and expand global market penetration Next-generation column technology enhances efficiency, expands recurring...

SPR announces reaching significant SPRINT PNS milestone with 50,000 treatment implants.

CALABASAS, Calif., Dec. 15, 2025 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (Nasdaq: NTHI) (“NeOnc” or the “Company”), a multi-Phase 2 clinical-stage biopharmaceutical company developing...

BetaGlue Receives Belgium Ministry of Health Approval for YntraDose® Clinical Trial in Unresectable Locally Advanced Pancreatic Cancer (uLA-PDAC)